Psychedelics Archives - Page 3 of 9

Legislative approaches that could improve access to psychedelic-based medicine

Testimony by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein

Legalizing psilocybin access in Arizona would benefit mental health

Backgrounder by Leonard Gilroy and Geoffrey Lawrence

Washington has a chance to examine ibogaine-assisted therapy benefits

Testimony by Madison Carlino

Psychedelics Policy Newsletter: States propose legalization, optimism for Trump administration nominee, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — February 2025

Commentary by Gregory Ferenstein

DEA’s increased DMT quota signals positive advancement in psychedelic research

Commentary by Madison Carlino

Rethinking the need for double-blind placebo trials in psychedelic clinical investigations

Commentary by Madison Carlino

Psychedelic treatment for neurodegenerative disorders

Policy Brief by Madison Carlino

Psychedelic therapy offers possible new hope for Alzheimer’s disease sufferers

Commentary by Madison Carlino

More Psychedelics

Prev
1
2
3
4
5
6
7
...
9
Next